| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 353.20B | 315.11B | 301.88B | 262.30B | 579.36B |
| Gross Profit | 69.46B | 51.57B | 47.24B | 36.92B | 28.75B |
| EBITDA | 46.85B | 31.75B | 28.03B | 17.32B | 1.67B |
| Net Income | 38.46B | 39.08B | 25.05B | 15.55B | -21.82B |
Balance Sheet | |||||
| Total Assets | 494.55B | 449.21B | 467.14B | 439.96B | 409.15B |
| Cash, Cash Equivalents and Short-Term Investments | 57.05B | 35.35B | 35.57B | 45.80B | 51.76B |
| Total Debt | 98.55B | 105.24B | 170.66B | 150.47B | 150.68B |
| Total Liabilities | 260.73B | 275.05B | 320.63B | 329.27B | 346.19B |
| Stockholders Equity | 229.10B | 169.85B | 142.10B | 106.54B | 57.22B |
Cash Flow | |||||
| Free Cash Flow | 19.32B | 5.22B | -41.64B | -22.44B | -29.25B |
| Operating Cash Flow | 28.42B | 14.85B | -34.44B | -15.04B | -20.27B |
| Investing Cash Flow | 2.55B | 60.90B | -354.00M | -3.00B | -70.92B |
| Financing Cash Flow | -10.42B | -76.57B | 24.11B | 9.52B | 806.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ¥239.27B | 11.89 | 16.64% | 1.36% | -0.12% | -17.83% | |
64 Neutral | ¥15.68B | 7.06 | ― | 0.27% | 5.30% | 126.07% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥630.77B | 20.40 | 4.83% | 2.95% | 2.18% | 5504.89% | |
59 Neutral | ¥417.74B | 11.17 | 13.69% | 0.60% | 12.09% | -1.60% | |
59 Neutral | ¥218.76B | 20.35 | ― | 2.41% | 5.68% | -49.64% | |
59 Neutral | ¥9.13B | 6.33 | ― | 2.71% | 7.29% | 20.12% |